期刊文献+

四川地区HIV/AIDS患者基因亚型及传播性耐药现状研究 被引量:5

Genetic Subtypes and Status of Transmitted Drug Resistance of HIV/AIDS Patients in Sichuan
原文传递
导出
摘要 目的分析四川地区初治HIV/AIDS患者的HIV基因亚型分布特点和传播性耐药现状。方法纳入四川地区住院且无抗反转录病毒治疗(ART)药物暴露史的成年HIV/AIDS患者,采用In-house测序法进行HIV基因测序,系统进化树判定HIV基因亚型,美国斯坦福大学HIV耐药数据库在线比对耐药突变位点并确定是否存在耐药及耐药种类、耐药水平。结果共纳入符合标准的120例患者,采集120份血液样本。87.5%样本HIV基因扩增成功(105/120),HIV基因亚型分布特点:CRF01_AE占比46.67%(49/105),CRF07_BC占比39.05%(41/105),其他占比14.28%(15/105)。不同性别、年龄、民族、感染途径、耐药、HIVRNA水平、CD4水平等基因亚型的差异均无统计学意义(P>0.05)。25份样本检测到耐药突变位点(20.83%),20份样本潜在耐药(16.67%),5份样本传播性耐药(4.17%)。24份样本对非核苷类反转录酶抑制剂(NNRTIs)耐药,V179D/E位点突变频率最高,1份样本对蛋白酶抑制剂耐药,突变位点M46I,未发现核苷类反转录酶抑制剂耐药及整合酶抑制剂耐药。结论四川地区初治住院成年HIV/AIDS患者HIV基因亚型分布特点以CRF01_AE和CRF07_BC为主,传播性耐药率较低,以NNRTIs耐药为主。进行HIV基线耐药检测对制定有效ART方案具有重要意义。 Objective To investigate the distribution characteristics of the HIV genetic subtypes and the status quo of transmitted drug resistance among HIV/AIDS patients in Sichuan with no previous history of receiving antiretroviral therapy(ART).Methods Adult HIV/AIDS patients who were hospitalized in Sichuan and who had no previous history of exposure to ART drugs exposure were enrolled.In-house sequencing of the HIV gene was done and phylogenetic tree was constructed to analyze the HIV genetic subtypes.The Stanford HIV drug resistance database was used to make online comparison of the drug resistance mutation sites and to determine the presence or absence of drug resistance,and the type and level of drug resistance.Results A total of 120 patients were enrolled for the study,and 120blood samples were collected.The genetic subtypes of 87.5%(105/120)of the samples were successfully amplified.The distribution characteristics of HIV genotype were as follows,CRF01_AE accounted for 46.67%(49/105),CRF07_BC accounted for 39.05%(41/105),and the others genetic subtypes,14.28%(15/105).There were no significant differences between the different genetic subtypes in sex,age,ethnicity,HIV transmission route,drug resistance,baseline HIV RNA and baseline CD4(P>0.05).Drug-resistant mutation sites were detected in 25 samples,accounting for 20.83%(25/120)of all samples,with 16.67%(20/120)being potential drug resistance and 4.17%(5/120)being transmitted drug resistance.For the 24 samples found to be resistant to non-nucleoside reverse transcriptase inhibitors(NNRTIs),the mutation frequency of V179D/E was the highest.One patient showed resistance to protease inhibitors(PI)and the mutation site was M46I.No nucleoside reverse transcriptase inhibitor(NRTI)or integrase inhibitors(INTI)resistance were found.Conclusions The main genetic subtypes of HIV/AIDS patients in Sichuan with no previous history of receiving ART were CRF01_AE and CRF07_BC.The incidence of transmitted drug resistance was low.The drug resistance detected in the study was predominantly resistance to NNRTIs.Baseline HIV drug resistance testing is of great significance for formulating effective ART regimens.
作者 刘欢霞 何盛华 周锐峰 何沅鸿 杨彤彤 姚远 LIU Huan-xia;HE Sheng-hua;ZHOU Rui-feng;HE Yuan-hong;YANG Tong-tong;YAO Yuan(Infectious Disease Department One,Chengdu Public Health Clinical Medical Center,Chengdu 610061,China)
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2022年第5期851-856,共6页 Journal of Sichuan University(Medical Sciences)
基金 四川省卫生和计划生育委员会科研课题(No.18PJ341)资助。
关键词 HIV/AIDS患者 抗病毒治疗 基因亚型 传播性耐药 HIV/AIDS patients Antiretroviral therapy Genotypes Transmitted drug resistance
  • 相关文献

参考文献7

二级参考文献94

  • 1尹春煜,卢洪洲,黄潇潇,李晓鸥,娄国强,翁心华.中国部分地区未经抗病毒治疗的hiv-1感染者耐药性突变分析[J].中华临床感染病杂志,2011,4(4). 被引量:5
  • 2Tian Xin CHU,Judith A LEVY.Injection drug use and HIV/AIDS transmission in China[J].Cell Research,2005,15(11):865-869. 被引量:17
  • 3汤恒,占发先,彭国平,陈慧萍,彭庭海,褚小刚.湖北省未经抗病毒治疗的HIV-1感染者的耐药基因变异分析[J].中国热带医学,2007,7(9):1505-1507. 被引量:5
  • 4谢美榕.福建省HIV-1耐药基因变异现况及MSMHIV-1感染者流行毒株亚型分析研究[D].福州:福建医科大学,2011.
  • 5Bobkova M. Current status of HIV-I diversity and drug resistance monitoring in the former USSR[J]. AIDS Rev, 2013, 15(4) :204-212.
  • 6He X, Xing H, Ruan YH, et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey [J ]. PLoS One,2012,7(10) : e47289.
  • 7Bhargava M, Cajas JM, Wainberg MA, et al. Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review [J]. J Int AIDS Soc, 2014, 17: 18944.
  • 8Sui HS, Gui T, Jia L, et al. Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study [ J ]. PLoS One, 2014,9 ( 3 ) : e91803.
  • 9Zeng PB, Liu Y, He M, et al. HIV-1 genotypic diversity and prevalence of drug resistance among treatment naxre HIV- infected individuals in Chengdu of China [ J]. Virus Genes, 2013, 47(3) :408-413.
  • 10Liu J, Yue J, Wu S, et al. Polymorphisms and drug resistance analysis of HIV-I CRF01_AE strains circulating in Fujian Province, China [J]. Arch Virol, 2007, 152 (10) : 1799-1805.

共引文献425

同被引文献43

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部